SCHEMBL7012345

SCHEMBL7012345

CCSc1nc2c(C(=O)OC)sc(C)c2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 4/20 0.41
CSNK2A1 P68400 4/20 0.41
CSNK2B P67870 2/20 0.41
HPGD P15428 3/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 6/20 0.36
MAPT P10636 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
MAPK1 P28482 2/20 0.35
GAA P10253 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2E1 P05181 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C8 P10632 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2B6 P20813 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9031610 0.90 CSNK2A2 (0.40) CSNK2A2CSNK2A1CSNK2BHPGDALDH1A1
SCHEMBL7012347 0.90 CSNK2A2 (0.41) CSNK2A2CSNK2A1CSNK2BHPGDKDM4E
SCHEMBL7014162 0.88 CSNK2A2 (0.41) CSNK2A2CSNK2A1CSNK2BHPGDKDM4E
SCHEMBL9033551 0.88 TSHR (0.46) CSNK2A2CSNK2A1CSNK2BHPGDKDM4E
SCHEMBL9031572 0.86 XDH (0.44) SMN1; SMN2CYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL9032280 0.85 HPGD (0.44) CSNK2A2CSNK2A1CSNK2BHPGDKDM4E
SCHEMBL9031781 0.85 CSNK2A2 (0.41) CSNK2A2CSNK2A1CSNK2BHPGDKDM4E
SCHEMBL9031788 0.85 CSNK2A2 (0.38) CSNK2A2CSNK2A1CSNK2BHPGDKDM4E
SCHEMBL9031798 0.84 CSNK2A2 (0.36) CSNK2A2CSNK2A1CSNK2BHPGDKDM4E
SCHEMBL9031878 0.82 KMT2A (0.34) CSNK2A2CSNK2A1CSNK2BHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
EP-0483683-B1 Thienoimidazole derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1996-02-28 EP disclosed
US-5463073-A Angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-10-31 US disclosed
US-5354766-A 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-11 US disclosed
US-5243054-A Hypotensive agents, cardiovascular disorders or nervous system disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-09-07 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed
EP-0483683-A2 Thienoimidazole derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1992-05-06 EP disclosed